Erythromycin A 6,9-imino ether
CAS: 99290-97-8
Ref. 3D-FE146285
1mg | 248.00 € | ||
2mg | 364.00 € | ||
5mg | 517.00 € | ||
10mg | 801.00 € | ||
25mg | 1,392.00 € |
Product Information
- (1Z,3R,4R,5S,6R,9R,10S,11S,12R,13R,15R)-10-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-6-ethyl-4,5-dihydroxy-3,5,9,11,13,15-hexamethyl-12-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-7,16-dioxa-2-azabicyclo[11.2.1]hexadec-1-en-8-one
- 7,16-Dioxa-2-azabicyclo[11.2.1]hexadec-1-en-8-one, 10-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-6-ethyl-4,5-dihydroxy-3,5,9,11,13,15-hexamethyl-12-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, [3R-(3R*,4R*,5S*,6R*,9R*,10S*,11S*,12R*,13R*,15R*)]-
- 7,16-Dioxa-2-azabicyclo[11.2.1]hexadec-1-en-8-one, 10-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-6-ethyl-4,5-dihydroxy-3,5,9,11,13,15-hexamethyl-12-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, (1Z,3R,4R,5S,6R,9R,10S,11S,12R,13R,15R)-
Erythromycin is a macrolide antibiotic that inhibits bacterial growth by binding to the 50S ribosomal subunit. It has been shown to have antibacterial activity against both staphylococci and streptococci. Erythromycin binds to the 23S ribosomal RNA, which prevents protein synthesis and cell division. The drug is used for the treatment of infections caused by bacteria susceptible to erythromycin, such as Group P2 (Streptococcus pneumoniae) and Group A (Staphylococcus aureus). Erythromycin also inhibits the biosynthesis of macrolactones, which are antibiotics related to erythromycin. These compounds are found in Streptomyces spp., Actinomycetes spp., and Mycobacterium smegmatis.
Chemical properties
Technical inquiry about: 3D-FE146285 Erythromycin A 6,9-imino ether
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.